Oakmont Partners LLC Buys Shares of 1,149 UnitedHealth Group Inc (UNH)

Oakmont Partners LLC bought a new position in UnitedHealth Group Inc (NYSE:UNH) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,149 shares of the healthcare conglomerate’s stock, valued at approximately $253,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Capital International Investors lifted its stake in shares of UnitedHealth Group by 399.3% in the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares during the period. Jennison Associates LLC lifted its stake in shares of UnitedHealth Group by 146.0% in the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares during the period. Janus Henderson Group PLC lifted its stake in shares of UnitedHealth Group by 1,820.1% in the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares during the period. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC lifted its stake in shares of UnitedHealth Group by 77.3% in the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares during the period. Institutional investors own 86.00% of the company’s stock.

Several brokerages recently commented on UNH. Deutsche Bank raised their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Jefferies Group reiterated a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research note on Friday, December 1st. Finally, Evercore ISI reiterated an “outperform” rating and issued a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a research note on Friday, January 12th. Two investment analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $243.22.

In other news, Director Michele J. Hooper sold 10,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the sale, the director now directly owns 37,284 shares in the company, valued at $8,864,643.84. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 53,396 shares of company stock valued at $12,262,067. Insiders own 0.89% of the company’s stock.

Shares of UnitedHealth Group Inc (NYSE UNH) opened at $229.37 on Friday. The company has a market cap of $222,270.00, a PE ratio of 24.14, a PEG ratio of 1.32 and a beta of 0.70. UnitedHealth Group Inc has a twelve month low of $156.49 and a twelve month high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.11 earnings per share. research analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.31%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.58%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://ledgergazette.com/2018/02/18/oakmont-partners-llc-buys-shares-of-1149-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply